section name header

Basics ⬇

DESCRIPTION

Acromegaly is a rare disorder caused by excess production of growth hormone (GH), usually from a pituitary adenoma, that almost always results in cardiomyopathy characterized by biventricular hypertrophy and potential diastolic and systolic heart failure. The cardiomyopathy is due to both direct effects of GH and insulin-like growth factor-1 (IGF-1), as well as secondary effects from HTN, diabetes, and other comorbid conditions.

EPIDEMIOLOGY

Incidence

The incidence of acromegaly is ~3–4 cases per million persons per year.

Prevalence

PATHOPHYSIOLOGY

ETIOLOGY

COMMONLY ASSOCIATED CONDITIONS

Diagnosis ⬆ ⬇

History

Physical Exam

DIAGNOSTIC TESTS & INTERPRETATION

Lab

Imaging

Diagnostic Procedures/Surgery

Endomyocardial biopsy is not routinely indicated for suspected acromegalic cardiomyopathy, as the histopathological findings are nonspecific.

Pathological Findings

DIFFERENTIAL DIAGNOSIS

Medication (Drugs) ⬆ ⬇

Treatment ⬆ ⬇

ADDITIONAL TREATMENT

General Measures

Additional Therapies

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

Routine measurement of serum IGF-1 and GH concentrations should be performed to assess effectiveness of treatment. Normal age- and sex-specific IGF-1 concentrations, and GH concentrations <2.5 ng/mL are associated with improvement in cardiac structure and function, as well as restoration of normal life expectancy.

PROGNOSIS

Miscellaneous ⬆ ⬇

CODES

ICD9

SNOMED

CLINICAL PEARLS

Reference(s) ⬆ ⬇

ADDITIONAL READING

Author(s) ⬆

Thomas M. Tadros

Deepak L. Bhatt

Gary S. Francis